CompletedPhase 4NCT02764697
Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
Studying Infectious scleritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Tampa Bay Uveitis Center, LLC
- Principal Investigator
- Grace L ClarkeTampa Bay Uveitis Center, LLC
- Intervention
- H.P. ACTHAR SUBCUTANEOUS GEL INJECTION(drug)
- Enrollment
- 6 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2016
Study locations (1)
- Tampa Bay Uveitis Center, St. Petersburg, Florida, United States
Collaborators
Mallinckrodt
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02764697 on ClinicalTrials.gov